Luca Sartori

Title: Luca Sartori: Innovator in E3 Ligase Inhibition

Introduction

Luca Sartori is a notable inventor based in Milan, Italy. He has made significant contributions to the field of molecular oncology, particularly through his innovative work on E3 ligase inhibitors. His research focuses on developing compounds that can potentially lead to advancements in cancer treatment.

Latest Patents

Luca Sartori holds a patent for "HECT E3 ligase inhibitors and uses thereof." This invention relates to tricyclic derivatives of formula (I), which are useful as inhibitors of HECT-domain-containing E3 ligases, specifically NEDD4. The patent also encompasses pharmaceutical compositions that include these compounds, their medical applications, and the processes for their preparation. He has 1 patent to his name.

Career Highlights

Throughout his career, Luca has worked with esteemed institutions such as the IFOM (Fondazione Istituto Firc Di Oncologia Molecolare) and the IEO (Istituto Europeo Di Oncologia S.r.l.). His work in these organizations has allowed him to contribute to groundbreaking research in oncology.

Collaborations

Luca Sartori has collaborated with notable colleagues, including Sebastiano Pasqualato and Maurizio Pasi. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Luca Sartori's innovative work in E3 ligase inhibitors showcases his commitment to advancing cancer treatment through scientific research. His contributions are significant in the ongoing battle against cancer, and his patent reflects his dedication to this vital field.